Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer

UnknownOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 18, 2018

Primary Completion Date

June 1, 2019

Study Completion Date

June 1, 2022

Conditions
Breast CancerRadiomicsNeoadjuvant ChemotherapyMulti-parametric MRI
Interventions
OTHER

neoadjuvant chemotherapy

neoadjuvant chemotherapy

Trial Locations (1)

100190

RECRUITING

Zhenyu Liu, Beijing

Sponsors
All Listed Sponsors
collaborator

Guangdong Provincial People's Hospital

OTHER

collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

collaborator

Beijing Friendship Hospital

OTHER

collaborator

Yunnan Cancer Hospital

OTHER

collaborator

Liaoning Cancer Hospital & Institute

OTHER

collaborator

First Hospital of China Medical University

OTHER

collaborator

Affiliated Hospital of Hebei University

OTHER

lead

Chinese Academy of Sciences

OTHER_GOV

NCT03592004 - Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer | Biotech Hunter | Biotech Hunter